![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Matsuno Keita Takada Ayato
Publisher: Future Medicine
ISSN: 1746-0794
Source: Future Virology, Vol.2, Iss.6, 2007-11, pp. : 607-614
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NCRNA Combined Therapy as Future Treatment Option for Cancer
Current Pharmaceutical Design, Vol. 20, Iss. 42, 2014-12 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
NAPc2 prolongs survival in Ebola virus infection
Inpharma, Vol. 1, Iss. 1418, 2003-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Gil Lizette Pérez Daniel Tápanes Rolando Pérez Jorge Grune Tilman
Redox Report, Vol. 10, Iss. 3, 2005-06 ,pp. :